Krogsgaard-Larsen Niels, Delgar Claudia G, Koch Karina, Brown Patricia M G E, Møller Charlotte, Han Liwei, Huynh Tri H V, Hansen Stinne W, Nielsen Birgitte, Bowie Derek, Pickering Darryl S, Kastrup Jette Sandholm, Frydenvang Karla, Bunch Lennart
Bowie Lab, Department of Pharmacology & Therapeutics, Faculty of Medicine, McGill University , Montreal, Quebec H3G 0B1, Canada.
J Med Chem. 2017 Jan 12;60(1):441-457. doi: 10.1021/acs.jmedchem.6b01516. Epub 2016 Dec 22.
Ionotropic glutamate receptor antagonists are valuable tool compounds for studies of neurological pathways in the central nervous system. On the basis of rational ligand design, a new class of selective antagonists, represented by (2S,4R)-4-(2-carboxyphenoxy)pyrrolidine-2-carboxylic acid (1b), for cloned homomeric kainic acid receptors subtype 1 (GluK1) was attained (K = 4 μM). In a functional assay, 1b displayed full antagonist activity with IC = 6 ± 2 μM. A crystal structure was obtained of 1b when bound in the ligand binding domain of GluK1. A domain opening of 13-14° was seen compared to the structure with glutamate, consistent with 1b being an antagonist. A structure-activity relationship study showed that the chemical nature of the tethering atom (C, O, or S) linking the pyrrolidine ring and the phenyl ring plays a key role in the receptor selectivity profile and that substituents on the phenyl ring are well accommodated by the GluK1 receptor.
离子型谷氨酸受体拮抗剂是研究中枢神经系统神经通路的重要工具化合物。基于合理的配体设计,获得了一类以(2S,4R)-4-(2-羧基苯氧基)吡咯烷-2-羧酸(1b)为代表的新型选择性拮抗剂,用于克隆的同源性海人藻酸受体亚型1(GluK1)(K = 4 μM)。在功能测定中,1b表现出完全的拮抗剂活性,IC = 6±2 μM。当1b结合在GluK1的配体结合结构域时,获得了其晶体结构。与谷氨酸结合的结构相比,观察到结构域开口为13-14°,这与1b作为拮抗剂一致。构效关系研究表明,连接吡咯烷环和苯环的连接原子(C、O或S)的化学性质在受体选择性方面起关键作用,并且苯环上的取代基能很好地被GluK1受体容纳。